Overview

Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to assess the efficacy and safety of different doses of rhNGF when administered as eye drops to patients with dry eye.
Phase:
Phase 2
Details
Lead Sponsor:
Dompé Farmaceutici S.p.A
Collaborator:
Cross Research S.A.
Treatments:
Mitogens